Viewing nowCombinationDapagliflozin and Sitagliptin Tablets 10/100 mg
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Eden Pharma Co., Ltd.

MFDS item code 202300293 · Approved 2023.01.18 · Insurance code 628902220
Improvement of blood sugar control in type 2 diabetes
This medication helps control blood sugar levels in patients with type 2 diabetes by using Sitagliptin and Dapagliflozin together. It is used to effectively improve blood sugar levels in conjunction with dietary restrictions and exercise therapy. Therefore, it serves as an important adjunctive treatment in the management of type 2 diabetes.
Sitagliptin 100 mg and Dapagliflozin 10 mg, taken once daily as 1 tablet regardless of meal. The tablet should be swallowed whole.
This medication may cause severe allergic reactions due to the Sitagliptin component; if an allergic reaction is suspected, discontinue use immediately and consult a doctor. This medication can cause severe side effects such as acute pancreatitis, marked by inflammation of the pancreas, so if symptoms such as abdominal pain, nausea, or vomiting occur during use, notify healthcare personnel immediately. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and in patients undergoing dialysis. In patients with decreased fluid volume or renal function issues, this medication may cause symptomatic hypotension or worsen renal function, so renal function and fluid status should be carefully assessed before and during use. This medication may increase the risk of genital and urinary infections, so rapid treatment should be sought if infection symptoms develop. As there is a risk of hypoglycemia, blood glucose levels must be carefully monitored and dosing adjusted if used in conjunction with insulin or sulfonylureas. Elderly patients are at higher risk for renal function decline and decreased fluid volume; hence, more caution is needed when taking this medication, and regular monitoring of renal function is recommended. Pregnant or lactating women should avoid using this medication, and it should be discontinued immediately if pregnancy is confirmed. If abnormal symptoms such as skin blisters, rash, or severe joint pain occur during use, notify a doctor immediately. In the case of overdose, no specific antidote is available, so appropriate treatment should be administered based on symptoms. While this medication does not greatly affect driving or machine operation, caution is advised as hypoglycemic symptoms may occur. The safety and efficacy of this medication in children have not been established, so it is advised not to administer it to patients under 18 years of age.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucous membranes, difficulty breathing or shortness of breath, asthma attack, respiratory abnormalities with cough and fever, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headache, lightning-like headache, seizures, confusion of consciousness, visual disturbances, paralysis, urination.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage will help maintain the effectiveness and safety of the medication for a prolonged period.
Beige oval film-coated tablets
30 tablets/box [(10 tablets/PTP X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Eden Pharma Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.